Higher efavirenz concentrations determine the response to viruses carrying non-nucleoside reverse transcriptase resistance mutations. [electronic resource]
- AIDS (London, England) Oct 2004
- 2091-4 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0269-9370
10.1097/00002030-200410210-00017 doi
Alkynes Anti-HIV Agents--therapeutic use Benzoxazines Cyclopropanes Drug Resistance, Viral--genetics HIV Infections--blood HIV-1--genetics Humans Mutation--genetics Nevirapine--therapeutic use Oxazines--blood Reverse Transcriptase Inhibitors--blood Treatment Failure Viral Load